FCH
PFE icon

Freestone Capital Holdings’s Pfizer PFE Stock Holding History

Freestone Capital Holdings’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-14,229
Closed -$388K – 364
2013
Q3 		$388K Buy
+14,229
New +$387K 0.07% 253

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Freestone Capital Holdings's PFE Position: Q2 2026 in Review

Freestone Capital Holdings increased its Pfizer (PFE) stake by 12% in Q2 2026, buying an estimated $159K and bringing the position to 55,761 shares worth $1.34M. The position accounts for 0.03% of the portfolio, ranked #230.

Freestone Capital Holdings first reported a position in PFE in Q3 2013 and has held it in 48 quarters since. The position peaked at $9.54M in Q4 2021. 2,828 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Freestone Capital Holdings held 55,761 shares of Pfizer worth $1.34M as of Q2 2026.
  • Freestone Capital Holdings bought 6,096 Pfizer shares in Q2 2026, an estimated $159K.
  • Pfizer made up 0.03% of Freestone Capital Holdings's portfolio in Q2 2026, its #230 holding.
  • Freestone Capital Holdings first reported a position in Pfizer in Q3 2013 and has held it in 48 quarters since.
  • Freestone Capital Holdings's Pfizer position peaked at $9.54M in Q4 2021.
  • 2,828 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Freestone Capital Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.